This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by DeBerry, B. B Articles by Chung, D. H Search for Related Content PubMed PubMed Citation Articles by DeBerry, B. B Articles by Chung, D. H Social Bookmarking                         What's this?

A survey for pain and sedation medications in pediatric patients during extracorporeal membrane oxygenation

Department of Surgery, The University of Texas Medical Branch, Galveston, TX, USA

James E Lynch

Department of Surgery, The University of Texas Medical Branch, Galveston, TX, USA

Jill M Chernin

Department of Surgery, The University of Texas Medical Branch, Galveston, TX, USA

Joseph B Zwischenberger

Department of Surgery, The University of Texas Medical Branch, Galveston, TX, USA

Dai H Chung

Department of Surgery, The University of Texas Medical Branch, Galveston, TX, USA, dhchung{at}utmb.edu

Routine administration of large amounts of pain and sedative medication is common to critically ill pediatric patients undergoing extracorporeal membrane oxygenation (ECMO) for cardiopulmonary failure. It has been our experience that pediatric patients are the most difficult age group in which to achieve an ideal pain and sedative control due to the narrow margin of safety. The purpose of this study was to determine the general practice guideline used for pain and anxiolytic pharmacotherapy for pediatric patients at ECMO centers. We sent a survey questionnaire to all ECMO centers in the USA that treat pediatric respiratory failure patients. Of the 46 responding centers (including telephone follow-ups), 37 (80%) centers had an active pediatric ECMO programs for patients with severe respiratory failure. Fentanyl was the most commonly used pain medication and continuous infusion, administered directly to the patient, was preferred. Subjective effectiveness of various pharmacological agents was variable without clear consensus; however, midazolam was considered to be the most effective agent used.

Perfusion, Vol. 20, No. 3, 139-143 (2005)
DOI: 10.1191/0267659105pf801oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?